Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
BMC Research Notes|November 8, 2013
Biochemical interaction of anti-HCV telaprevir with the ABC transporters P-glycoprotein and breast cancer resistance proteinYuria Fujita, Kohji Noguchi, Tomonori Suzuki, et al.
Cancer Science|November 22, 2022
Kaposi's sarcoma-associated herpesvirus replication and transcription activator protein activates CD274/PD-L1 gene promoterMasanori Miyazawa, Yuichiro Yamamoto, Kazuhiro Katayama, et al.
Cancer Science|August 24, 2006
Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cellsKazuyoshi Mutoh, Satomi Tsukahara, Junko Mitsuhashi, et al.
Cancer Science|March 30, 2010
Pharmacological interaction with sunitinib is abolished by a germ-line mutation (1291T>C) of BCRP/ABCG2 geneHaruka Kawahara, Kohji Noguchi, Kazuhiro Katayama, et al.
Cancer Science|June 4, 2010
BCRP/ABCG2 confers anticancer drug resistance without covalent dimerizationJunichi Shigeta, Kazuhiro Katayama, Junko Mitsuhashi, et al.
Biochimica Et Biophysica Acta. General Subjects|January 7, 2021
Regulation of N-glycosylation and secretion of Isthmin-1 by its C-mannosylationSatoshi Yoshimoto, Kazuhiro Katayama, Takehiro Suzuki, et al.
Anticancer Research|April 12, 2003
Cdk4/cyclin D1 kinase, a universal and critical regulator of apoptosisKazuhiro Katayama, Yoh Dobashi, Masatoshi Kitagawa, et al.
Cancer Science|October 5, 2016
Effect of AKT3 expression on MYC- and caspase-8-dependent apoptosis caused by polo-like kinase inhibitors in HCT 116 cellsYuma Nonomiya, Kohji Noguchi, Noritaka Tanaka, et al.
Cancer Chemotherapy and Pharmacology|March 9, 2007
Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationshipKazuhiro Katayama, Kazuto Masuyama, Sho Yoshioka, et al.
Pageof 14